Summary: Helius Medical Technologies Inc. has surpassed initial enrollment targets for its stroke registrational program evaluating PoNS Therapy, a novel neuromodulation approach to improve gait and ...

As you can see from the chart above the percentage of shares that are sold short for Helius Medical Tech has grown since its last report. This does not mean that the stock is going to fall in the ...

Helius Medical (HSDT) Technologies announced positive results from the PoNS Therapeutic Experience Program, or PoNSTEP, study for people with multiple sclerosis. PoNSTEP Results: There were ...

Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately ...

This page features the latest news about the Helius Medical A stock. Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 ...

NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 million, has surpassed its initial enrollment target for its stroke ...

Helius Medical (HSDT) Technologies announced it has completed and far exceeded the initial target enrollment for its stroke registrational program. With 128 participants randomized to-date the ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

(RTTNews) - Helius Medical Technologies (HSDT), a neurotech company focused on innovative treatments for neurological deficits, on Tuesday announced strong progress in its stroke registrational ...